Blitz Daily: Institutional Buyers Take a Shot at Pfizer

To view this email as a web page, go here.

Blitz Daily: Institutional Buyers Take a Shot at Pfizer In Wednesday’s Blitz Daily with Lance Ippolito, we’ll take a look at pharmaceutical company Pfizer Inc. (NYSE: PFE) after the company’s earnings surprise launched a barrage of bullish bets in the options chain.  PFE released second-quarter earnings before the opening bell Wednesday, which revealed that the drug maker topped consensus estimates and raised its full-year guidance by 10%. This news, along with a new order for another 200 million doses of its COVID-19 vaccines, was enough to send traders into a buying frenzy. PFE shares jumped more than 3.5% on the day, hitting a new 52-week high. So institutional traders are climbing over themselves to buy the options.  On top of this action, The Blitz Tracker also spotted the whales on Wall Street making big moves on three other positions… Click Here for Today’s Top Order Flow! All the best,   A New Money Crew Publication   Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information. Manage Your Email Preferences Unsubscribe This email was sent by: WealthPress 7751 Belfort Parkway #120 Jacksonville, FL, 32556, US Update Profile